COCRYSTAL PHARMA, INC. Income Tax Credits and Adjustments
COCRYSTAL PHARMA, INC. (COCP) reported Income Tax Credits and Adjustments of $699.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxCreditsAndAdjustments · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. income tax credits and adjustments for the quarter ending 2026-06-30 was $8.00K.
- COCRYSTAL PHARMA, INC. income tax credits and adjustments for the quarter ending 2026-03-31 was $691.00K.
| Period end | Income Tax Credits and Adjustments 3 month | Income Tax Credits and Adjustments 6 month | Income Tax Credits and Adjustments 12 month |
|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $699.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $691.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $662.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |